A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

NCT07029139 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: JMT601 Injection
DRUG: Rituximab
DRUG: Cyclosporin Capsules

Sponsor

Shanghai JMT-Bio Inc.